ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AOR Aortech International Plc

126.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 126.50 123.00 130.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Aortech Share Discussion Threads

Showing 3551 to 3574 of 8900 messages
Chat Pages: Latest  152  151  150  149  148  147  146  145  144  143  142  141  Older
DateSubjectAuthorDiscuss
21/11/2017
08:45
BBh - would take a bit of a court victory and improvement in sales to get that high wouldn’t it?
semper vigilans
20/11/2017
22:49
Has to be a great sign today .
£1 very possible by Christmas .

Best of Luck All

bbr391
20/11/2017
12:50
AorTech Shares Leap On Potential Settlement In Long-Running Dispute
By Alliance | Mon, 20th November 2017 - 09:57
Share this
LONDON (Alliance News) - Shares in AorTech International PLC leapt to the top of AIM after it announced it had reached a settlement in principle regarding an ongoing legal dispute with its former chief executive officer and Foldax Inc.

The medical device intellectual property company said it was responding to media reports. It added that a joint motion was issued in a court in the US state of Utah by Aortech and the Foldax defendants.

The joint motion declared that AorTech and the defendants had "reached a settlement in principle to resolve all claims in this case" and therefore asked for a stay to proceedings to "continue these productive settlement negotiations."

"If these negotiations are successful," the motion explained, "the parties will file a stipulated motion to dismiss with prejudice. If the parties are unable to successfully negotiate a settlement, the parties will provide notice to the court and ask that the stay be lifted."

AorTech will issue a further statement in due course, it said.

AorTech had raised a case against its former Chief Executive Officer Frank Maguire, who had resigned in November 2013. AorTech had claimed that several matters arose after his resignation which raised "serious concerns".

AorTech claimed Maguire had sought to undertake business transactions with existing and potential licensees without notifying the board.

It also claimed Maguire had negotiated with individuals at Foldax regarding a potential heart valve deal. Maguire subsequently joined Foldax in a senior position.

In a separate announcement on Monday, AorTech said it had appointed Stockdale Securities Ltd as its nominated adviser and broker with immediate effect.

Shares in AorTech were 13% higher at 20.25 pence on Monday.

By Ahren Lester; ahrenlester@alliancenews.com.

Copyright 2017 Alliance News Limited. All Rights Reserved.

the stigologist
20/11/2017
12:33
I'm guessing Foldax due a funding round and the litigation risk hanging over them would make it a difficult sell
the stigologist
20/11/2017
11:47
Shows what could happen if there is real positive news
the stigologist
20/11/2017
09:50
I agree for once, all looks a lot more positive going forward
cocker
20/11/2017
08:28
The settlement should be the end of the Maguire era. The new broker and Nomad looks like a positive first step for the future.
landy90
20/11/2017
08:05
I've known stocks go up a lot on settlements. Looks promising despite any guidance on likely figures
the stigologist
20/11/2017
07:41
Fingers crossed for a good and quick settlement. Well done to Bill for sticking with this!
gac141
17/11/2017
10:40
Given they have licensed the core material tech to a third party to sell and market I am not sure they much that much else to do !!
harrogate
17/11/2017
10:39
there is always a cost it's the same principle of 'no such thing as a free lunch' there is at least an opportunity cost of using those same resources in some other more productive capacity
the stigologist
17/11/2017
09:46
Hi. I agree on the distraction but as it is us suing them I can't see much cost as we have been insured on the proceedings. I expect us to get some cash here
harrogate
17/11/2017
09:34
As a distraction and potential unquantifiable cost just drawing a line under it might be enough to have significant impact.
the stigologist
17/11/2017
09:05
Well read Harrogate, "completion" does suggest they are nearer the end of the process than the start. The "Stay" would stop the court publishing its decisions on summary judgement which have been due for a while avoiding any adverse ruling on the public record.
landy90
17/11/2017
07:29
Thanks for the info Landy - hope it bodes well for AOR.
semper vigilans
17/11/2017
07:25
After 3 months of no news on Pacer about the litigation, a motion to suspend the case pending settlement discussions.
landy90
28/9/2017
19:14
Did anyone bother to go to the agm?
cocker
26/9/2017
08:31
Agm tomorrow. What's the chances of any news?
cocker
14/9/2017
08:45
whoa giddy up

Seems in a hurry

the stigologist
14/9/2017
07:46
What's going on there!
davisc5
14/9/2017
07:43
He now has 10% Stig !
cocker
11/9/2017
13:15
Ex director - that is what makes it a bit more interesting for me.
harrogate
11/9/2017
13:06
I have not been Aortech's biggest fan over the last few years, having said that when a director digs deep to up his stake, it does install a huge amount of confidence. Perhaps worth a punt maybe at these levels !
cocker
11/9/2017
10:52
Seems this is well off the radar
the stigologist
Chat Pages: Latest  152  151  150  149  148  147  146  145  144  143  142  141  Older

Your Recent History

Delayed Upgrade Clock